Lightbridge Provides Business Update and Announces First Quarter 2024 Financial Results
RESTON, Va., May 09, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced...
RESTON, Va., May 09, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced...
Seminal Phase 2b ASCEND trial top-line data expected in fourth quarter of 2024Projected available cash to fund planned operations into...
Delivered Q1 2024 revenue of $9.0 million Reported net loss of $2.4 million and adjusted EBITDA1 loss of $0.9 million...
PALIZADE Phase 2b clinical trial of zetomipzomib in patients with active lupus nephritis actively enrolling; reiterating guidance of topline data...
— $152.0 million cash runway into the second half of 2026 —— A study update on KB-0742-1001 will be presented...
WALTHAM, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from...
Strong Momentum for Amtagvi™ (Lifileucel) U.S. Launch Following U.S. Food and Drug Administration (FDA) Approval100+ Amtagvi Patients Enrolled Across More Than...
- Presented new preclinical data demonstrating proof-of-concept for non-signaling Chimeric Antigen Receptor (nsCAR) platform to effectively target cancer cells while...
Expanded Gross Profit Margin to 49.4% Following Strong Execution of Operational Improvement PlanNet Loss of $18.4 Million, Compared to $12.4...
Growth in B2B revenues and reduced operating expenses offset by unfavorable B2C sports margin Merger with SegaSammy remains on track...
HOUSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Freight Technologies, Inc. (Nasdaq: FRGT, “Fr8Tech” or the “Company”), a technology company offering...
First Lupus Patient Treated with FT819 CAR T-cell Product Candidate in Phase 1 Autoimmunity Study; Future Clinical Development of FT819...
Expensify Card interchange grew to $3.5 million, Operating cash flow was $3.5 million and Free cash flow was $5.2 million....
Contacts Everbridge Contacts: Investors: Nandan Amladi Investor Relations nandan.amladi@everbridge.com 617-665-7197 Media: Jeff Young Media Relations jeff.young@everbridge.com 781-859-4116 Everbridge, Inc. (Nasdaq:...
• Q1 2024 revenue of $8.0 million, representing 50% growth over Q1 2023 and the 13th straight quarter of sequential product...
$32.3 million cash balance at the end of Q1 2024 expected to provide cash runway into 2H 2025 Announced positive...
Dose escalation of zotatifin in the ZFA triplet ongoing at 0.14 mg/kg, with RP2D expected in H2 2024Raised $15.0 million...
Contacts Cutera, Inc. Greg Barker VP, Corporate FP&A and Investor Relations 415-657-5500 IR@cutera.com Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the...
Contacts Investor Contact: Massimo Disabato, CommScope +1 630-281-3413 Massimo.Disabato@commscope.com News Media Contact: publicrelations@commscope.com The stockholders of CommScope Holding Company, Inc.,...
The agreement includes the potential to expand the sites by an additional 55 MW Wyoming now third state in Company's...
CARLSBAD, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results...
Adjusted EBITDA Increased 173% Contacts Pat Cunnane pcunnane@entercom.com Audacy, Inc. (OTC: AUDAQ) today reported financial results for the quarter ended...
First quarter 2024 revenue of $339 million, representing an increase of 2% year-over-year and adjusted gross margin(1) of 48% First...
Dose escalation of zotatifin in the ZFA triplet ongoing at 0.14 mg/kg, with RP2D expected in H2 2024Raised $15.0 million...
PARSIPPANY, NJ, May 09, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial...
Reduces Operating Expense by over $5 million and Net Loss by over 50% compared to 2023 TAMPA, Fla., May 9,...
Contacts Investor and Media Contact: Alpine Immune Sciences, Inc. ir@alpineimmunesciences.com media@alpineimmunesciences.com Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage...
Pharmaloz Manufacturing explores strategic alternatives, including potential sale.Company announces major strategic AI initiative, Project ZenQ-AI, leveraging its massive global genomics...
AUSTIN, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a late-stage biopharmaceutical company focused on therapeutics for...
MINNEAPOLIS, May 09, 2024 (GLOBE NEWSWIRE) -- Sun Country Airlines (NASDAQ: SNCY) President and Chief Financial Officer Dave Davis will...
SALINAS, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (CSE:LOWL; OTCQX:LOWLF), a California-born cannabis company with advanced production capabilities...
Provides Update on Pilar Drill Program CALGARY, AB / ACCESSWIRE / May 9, 2024 / Tocvan Ventures Corp. (the "Company")...
CHICAGO, May 9, 2024 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today announced the preliminary shareholder voting results from its...
From e-commerce to student success to patient engagement, innovators drive impressive business results and engagement using Bandwidth's text messaging platform Read...
The new financial center at 2501 Blue Ridge Road includes full-service retail and commercial banking MARTINSVILLE, VA / ACCESSWIRE /...
NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Fluent, Inc. (NASDAQ: FLNT) announced today that it will report its financial...
Contacts Advent Technologies Holdings, Inc. Michael Trontzos press@advent.energy Advent Technologies Holdings, Inc. (Nasdaq: ADN) (“Advent” or the “Company”) announced today...
Highlights Two leases have been granted near the Sky Project, providing an additional 5.2km2 in the highly prospective region. Sky...
VANCOUVER, BC and HONG KONG / ACCESSWIRE / May 9, 2024 / Reyna Silver Corp. (TSXV:RSLV)(OTCQX:RSNVF)(FRA:4ZC) ("Reyna" or the "Company")...
USA News Group Commentary Issued on behalf of Bee Vectoring Technologies International Inc. VANCOUVER, BC, May 9, 2024 /PRNewswire/ -- USA...